BeStock  
Stocks › Biotechnology › ZVRA

Zevra Therapeutics ZVRA

US equityMarket cap rank #3557Biotechnology
$11.08 +$0.35 (+3.26%)
Pre-market · Oct 8, 7:00 am ET · After hours $11.19 +0.99%
Open$10.68
Prev close$10.73
Day range$10.57 – $11.38
Volume936.5K
Market cap$657.97M
P/E (TTM)11.9
Dividend yield–

ZVRA Stock News

Headlines matching Zevra Therapeutics or the ZVRA ticker, most recent first.

  • H.C. Wainwright Maintains Zevra Therapeutics(ZVRA.US) With Buy Rating, Maintains Target Price $26Market news · 22 Sep 2026 · Direct mention
  • Zevra Therapeutics (ZVRA) Receives a Buy From H.C. WainwrightTipRanks · 22 Sep 2026 · Direct mention
  • Maxim Group Maintains Zevra Therapeutics(ZVRA.US) With Buy Rating, Maintains Target Price $35Market news · 8 Aug 2026 · Direct mention
  • Guggenheim Maintains Zevra Therapeutics(ZVRA.US) With Buy Rating, Cuts Target Price to $23 NegativeMarket news · 7 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for Zevra Therapeutics(ZVRA.US), With a Forecast Between $21 to $28Market news · 7 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for Zevra Therapeutics(ZVRA.US), With a Forecast Between $24 to $28Market news · 6 Aug 2026 · Direct mention
  • CCORF Maintains Zevra Therapeutics(ZVRA.US) With Buy Rating, Maintains Target Price $20Market news · 12 Aug 2026 · Direct mention
  • CCORF Maintains Zevra Therapeutics(ZVRA.US) With Buy Rating, Cuts Target Price to $20 NegativeMarket news · 27 Jul 2026 · Direct mention
  • BTIG Maintains Zevra Therapeutics(ZVRA.US) With Buy Rating, Cuts Target Price to $24 NegativeMarket news · 27 Jul 2026 · Direct mention
  • William Blair Maintains Zevra Therapeutics(ZVRA.US) With Buy RatingMarket news · 25 Jul 2026 · Direct mention
  • Roth MKM Maintains Zevra Therapeutics(ZVRA.US) With Buy Rating, Maintains Target Price $21Market news · 24 Jul 2026 · Direct mention
  • BTIG Maintains Zevra Therapeutics(ZVRA.US) With Buy Rating, Maintains Target Price $27Market news · 1 Jul 2026 · Direct mention
  • A Quick Look at Today's Ratings for Zevra Therapeutics(ZVRA.US), With a Forecast Between $25 to $34Market news · 9 Jun 2026 · Direct mention
  • CCORF Maintains Zevra Therapeutics(ZVRA.US) With Buy Rating, Maintains Target Price $24Market news · 2 Jun 2026 · Direct mention
  • Maxim Group Maintains Zevra Therapeutics(ZVRA.US) With Buy Rating, Raises Target Price to $35 PositiveMarket news · 11 Jun 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on ZVRA.

Leave a comment

Scroll to Top